Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt | ($1,253.6M) | ($1,937.1M) | $473.7M | $139.9M | ($512.6M) | ($403.0M) | $1,493.3M | ($2,437.0M) | $5,642.0M | $4,146.5M | $678.0M | ($4,151.0M) | ($6,034.0M) | ($3,152.0M) | ($4,190.0M) | ($621.0M) | $23.5B | $19.4B | $17.6B | $17.7B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Gilead Sciences, Inc.'s last 12-month Net Debt is $18.2B, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Gilead Sciences, Inc.'s Net Debt growth was 7.4%. The average annual Net Debt growth rates for Gilead Sciences, Inc. have been (8.7%) over the past three years, 159.1% over the past five years.
Over the last year, Gilead Sciences, Inc.'s Net Debt growth was 7.4%, which is higher than industry growth of 0.3%. It indicates that Gilead Sciences, Inc.'s Net Debt growth is Bad.